Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Marianna Rondini
Observed names:
M Rondini,
M. Rondini
Institutions:
University of Pisa,
Azienda Sanitaria Ospedaliera S.Croce e Carle Cuneo,
Ospedale Versilia
Observed institutions:
University of Pisa,
Azienda Sanitaria Ospedaliera S.Croce e Carle Cuneo,
Ospedale Versilia,
Azienda Ospedaliera Universitaria Pisana
OpenAlex ID:
A5056148665
Activity of first-line epirubicin and paclitaxel in metastatic breast cancer is independent of type of adjuvant therapy
2004
·
A Gennari
, P Bruzzi
, et al.
·
British Journal of Cancer
·
51
PDF
Hormonotherapy of advanced prostate cancer
2005
·
P. Pronzato
, M. Rondini
·
Annals of Oncology
·
42
Optimal Detection of Sentinel Lymph Node Metastases by Intraoperative Radioactive Threshold and Molecular Analysis in Patients with Melanoma
2008
·
Gianpiero Manca
, Antonella Romanini
, et al.
·
Journal of Nuclear Medicine
·
40
PDF
Phase II trial of single-agent oral vinorelbine in elderly (≥70 years) patients with advanced non-small-cell lung cancer and poor performance status
2009
·
A. Camerini
, C. Valsuani
, et al.
·
Annals of Oncology
·
31
PDF
First line chemotherapy of metastatic breast cancer
2006
·
P. Pronzato
, M. Rondini
·
Annals of Oncology
·
28
PDF
Primary chemotherapy with gemcitabine, epirubicin and taxol (GET) in operable breast cancer: a phase II study
2005
·
P F Conte
, S Donati
, et al.
·
British Journal of Cancer
·
13
PDF
Weekly Docetaxel/Paclitaxel in Pretreated Metastatic Breast Cancer
2002
·
Alessandra Gennari
, Valentina Guarneri
, et al.
·
Clinical Breast Cancer
·
7
Sorafenib in a patient with advanced hepatocellular carcinoma and serious impairment of left ventricular function: a case report
2009
·
Chiara Valsuani
, Olimpia Siclari
, et al.
·
Cases Journal
·
4
PDF
Fulvestrant treatment is associated with cholesterol plasma level reduction in hormone receptor-positive metastatic breast cancer patients
2009
·
Andrea Camerini
, Marianna Rondini
, et al.
·
Cancer Biology & Therapy
·
3
PDF
Bevacizumab (BV) in combination with folfoxiri (Irinotecan, Oxaliplatin and Infusional 5FU/LV) as first-line treatment of metastatic colorectal cancer (mCRC): a phase II trial by the GONO GROUP
2009
·
Gianluca Masi
, Enrico Vasile
, et al.
·
CINECA IRIS Institutial research information system (University of Pisa)
·
3
Combination of trastuzumab, oxaliplatin, and docetaxel as first-line treatment in HER2-positive metastatic breast cancer patients: First-step results of a phase II trial (HOT trial)
2009
·
D. Amoroso
, S. Donati
, et al.
·
Journal of Clinical Oncology
·
2
Effect of fulvestrant treatment on serum VEGF levels in hormone-sensitive metastatic breast cancer patients
2009
·
A. Camerini
, O. Garrone
, et al.
·
Journal of Clinical Oncology
·
1
Toxicity of adjuvant treatment with high-dose interferon alpha 2b (HD-IFN) in high-risk stage III melanoma patients (pts): The Italian experience
2005
·
A. Romanini
, S. Sarti
, et al.
·
Journal of Clinical Oncology
·
1
Femoral Artery Leiomyosarcoma: Case Report and Literature Review
2021
·
Giuseppe Baldino
, Alessio Amico
, et al.
·
Annals of Vascular Surgery
1725P Development and validation of telematic follow-up for cancer patients during the COVID-19 outbreak
2020
·
A. Pastorino
, M.E. Negru
, et al.
·
Annals of Oncology
PDF
Development and validation of telematic follow-up for cancer patients during the covid-19 outbreak at the medical oncology unit of sant'andrea and san bartolomeo hospitals, la spezia
2020
·
Alessandro Pastorino
, M.E. Negru
, et al.
·
Tumori
Clinical and genetic characterization of dihydropyrimidine dehydrogenase (DPD) deficiency in fluoropyrimidine-treated patients carrying the DPYD*2A allele
2011
·
Marzia Del Re
, C. Barbara
, et al.
·
CINECA IRIS Institutial research information system (University of Pisa)
Combination of trastuzumab, oxaliplatin and docetaxel as first line treatment in HER2-positive advanced breast cancer patients: preliminary results of a phase II trial (HOT Trial)
2009
·
D. Amoroso
, Sara Donati
, et al.
·
CINECA IRIS Institutial research information system (University of Pisa)
Correlation of HER2 overexpression evaluated by fluorescence in situ hybridization with response to docetaxel-based first-line chemotherapy in advanced breast cancer patients
2008
·
A. Cavazzana
, A. Camerini
, et al.
·
Journal of Clinical Oncology
Phase II trial of single agent oral vinorelbine in elderly (≥70 years) patients with advanced non small cell lung cancer and poor performance status
2008
·
D. Amoroso
, A. Camerini
, et al.
·
Journal of Clinical Oncology
Phase II study of irinotecan, oxaliplatin and infusional 5FU/LV (GONO-FOLFOXIRI) plus bevacizumab (BV) as first-line treatment in metastatic colorectal cancer (MCRC)
2008
·
Gianluca Masi
, Fotios Loupakis
, et al.
·
CINECA IRIS Institutial research information system (University of Pisa)
Outcomes of metastatic breast cancer patients older than 60 years treated with FEC or ET regimens: A retrospective analysis
2003
·
Alessandra Gennari
, Valentina Guarneri
, et al.
·
Padua Research Archive (University of Padova)
Show more works
View as search
Works count:
22
Citation count:
226
H-index:
7
I10-index:
6
Year
Topic
Type